Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.42 USD
+0.15 (0.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $65.42 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Price, Consensus and EPS Surprise
GILD 65.42 +0.15(0.23%)
Will GILD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GILD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GILD
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
Other News for GILD
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
June 7th Options Now Available For Gilead Sciences (GILD)
3 Dividend Stocks to Buy at a 52-Week Low in April
Gilead Sciences declares $0.77 dividend
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV